Immunomodulation of autoimmunity by linomide.
Karussis
D M
DM
Department of Neurology, Hadassah University Hospital, Jerusalem, Israel.
Lehmann
D
D
Slavin
S
S
Kalland
T
T
Vourka-Karussis
U
U
Mizrachi-Koll
R
R
Ovadia
H
H
Abramsky
O
O
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000284:Administration, Oral; D000818:Animals; D015551:Autoimmunity / Q000187:drug effects*; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology / Q000473:pathology / Q000517:prevention & control*; D006912:Hydroxyquinolines / Q000627:therapeutic use*; D015979:Killer Cells, Lymphokine-Activated / Q000187:drug effects; D051379:Mice; D051381:Rats; D012008:Recurrence
D000276:Adjuvants, Immunologic; D006912:Hydroxyquinolines; C045282:roquinimex